English: One - that was in the Llyn peninsula the week before last, I believe. We have over 600 community pharmacies, and we must ensure that they become part of the vaccination process as soon as possible. They want to participate. A pharmacist in my constituency in Valley contacted me over the past few days, saying, 'We want to do this, we are trained to do it, we have capacity to do it, let us do it.' If I may say so, the clear message I hear is: 'We could do much more if we had more of the vaccine.' Now, I've asked time and time again for data on how many of the various vaccines have been distributed to the four nations of the UK, how many are provided to each health board here. I ask again. You've mentioned the importance of transparency in your opening remarks. Well, provide that transparency here so that we can see any inequalities or blocks in the system. It is crucial, fundamentally important data. Finally, I want to highlight the most recent concerns about that change of policy so that there would be up to a 12-week delay between the two doses of the Pfizer vaccine rather than the original three weeks. More concerns have been brought to my attention on this issue. There are concerns that it could undermine the effectiveness of the vaccination to the extent that you would have to start from the beginning. Now, I understand the idea of providing greater protection to more people, but are you willing to face the possibility that, to all intents and purposes, millions of vaccinations could have been wasted because of this change of policy?
Welsh: Un - hwnnw ym Mhenllyn yr wythnos cyn diwethaf, dwi'n cymryd rydych chi'n cyfeirio ato fo. Mae gennym ni dros 600 o fferyllfeydd cymunedol. Mae'n rhaid sicrhau eu bod nhw'n dod yn rhan o'r broses frechu mor fuan â phosib. Maen nhw eisiau cymryd rhan. Mi wnaeth fferyllydd yn fy etholaeth i, yn y Fali, digwydd bod, gysylltu yn y dyddiau diwethaf yn dweud, 'Rydyn ni eisiau gwneud. Mae gennyn ni le, rydyn ni wedi ein hyfforddi i wneud, gadewch inni wneud.' Ac os caf i ddweud, y neges glir dwi yn ei chlywed ydy: 'Mi allwn ni wneud llawer mwy pe baen ni'n cael mwy o'r brechiad.' Rŵan, dwi wedi gofyn dro ar ôl tro ar ôl tro am ddata ar faint o'r gwahanol frechiadau sydd wedi cael eu rhannu i bedair cenedl y Deyrnas Unedig, faint wedyn sy'n cael eu rhannu o bob un i bob bwrdd iechyd yma. Dwi'n gofyn eto. Rydych chi wedi sôn am bwysigrwydd tryloywder yn eich cyflwyniad chi. Rhowch y tryloywder inni yn fan hyn fel ein bod ni'n gallu gweld unrhyw anghyfartaleddau neu flocs yn y system. Mae o'n wybodaeth, mae o'n ddata cwbl, cwbl sylfaenol. Yn olaf, dwi eisiau tynnu sylw at y pryderon diweddaraf am y newid polisi hwnnw a fu fel bod hyd at 12 wythnos o oedi rhwng dau ddos y brechiad Pfizer yn hytrach na'r tair wythnos gwreiddiol. Mae yna fwy o bryderon wedi'u tynnu i'm sylw am hyn: poeni y gallai hynny fod yn effeithio a thanseilio effeithlonrwydd y brechiad i'r graddau eich bod chi'n gorfod dechrau o'r dechrau pan fo'n cyrraedd at y 12 wythnos. Dwi'n deall y syniad o roi rhywfaint o warchodaeth i fwy o bobl - wrth gwrs fy mod i'n deall hynny - ond ydych chi'n barod i wynebu'r posibilrwydd y gallai, i bob pwrpas, filiynau o frechiadau wedi cael eu gwastraffu oherwydd y newid polisi hwnnw?